![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » ANGIOTECH SIGNS GENZYME DEAL
ANGIOTECH SIGNS GENZYME DEAL
May 10, 2006
Angiotech Pharmaceuticals Inc., best known for its drug-coated stents, reported lower profits Tuesday but said it has signed a deal to develop cancer treatments with U.S. biotechnology company Genzyme (Nasdaq:GENZ).
Canoe Money
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct